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Vertebrate primary cilium is a Hedgehog signaling center but the
extent of its involvement in other signaling systems is less well
understood. This report delineates a mechanism by which fibro-
blast growth factor (FGF) controls primary cilia. Employing pro-
teomic approaches to characterize proteins associated with the
FGF-receptor, FGFR3, we identified the serine/threonine kinase
intestinal cell kinase (ICK) as an FGFR interactor. ICK is involved
in ciliogenesis and participates in control of ciliary length. FGF
signaling partially abolished ICK’s kinase activity, through FGFR-
mediated ICK phosphorylation at conserved residue Tyr15,
which interfered with optimal ATP binding. Activation of the
FGF signaling pathway affected both primary cilia length and
function in a manner consistent with cilia effects caused by in-
hibition of ICK activity. Moreover, knockdown and knockout of
ICK rescued the FGF-mediated effect on cilia. We provide con-
clusive evidence that FGF signaling controls cilia via interaction
with ICK.
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In vertebrates, the signaling of Hedgehog (Hh) morphogensdepends entirely on primary cilium. The cilia provide a struc-
tural and functional compartment that integrates a series of in-
tricate molecular mechanisms allowing cells to process Hh-target
transcriptional regulators and alter gene-expression programs in
response to Hh (1). Giving the rapidly growing importance of
primary cilia in the regulation of physiologic and pathologic
cellular functions (2), many other signaling systems are antici-
pated to work through the cilia.
Several recent lines of evidence demonstrate that fibroblast
growth factors (FGF) regulate primary cilia. Inactivation of the
FGF-receptor Fgfr1 or its FGF ligands lead to shorter cilia in
zebrafish and Xenopus (3). In mammals, FGF signaling regu-
lates the length of primary cilia in skin fibroblasts, lung, kidney,
and liver cells, human embryonic stem cells and human induced
pluripotent stem cells, embryonal fibroblasts, and mesenchymal
cells (4). In addition, the human skeletal dysplasias caused by
activating FGFR3 mutations, such as achondroplasia, manifest
by abnormal cilia (4, 5). Evidence strongly suggests that FGF
signaling integrates cilia into the canonical FGF signaling
pathway. However, the mechanism through which FGFs regu-
late primary cilia is not known.
Several serine/threonine kinases control ciliogenesis or other
specific functions of primary cilia. These “ciliary kinases” include
TTBK2 and GSK3β, involved in initiation of ciliogenesis and
assembly of the ciliary membrane (6, 7), NEK2, which regu-
lates cilia disassembly (8), and CK1 and GRK2, which are
important for Smoothened (SMO) translocation into the cilia
(9). The MAP-kinase superfamily kinase intestinal cell kinase
(ICK) is another well-known regulator of primary cilia, con-
served in this function from single-cell organisms to mammals.
Deletion of ICK or its homologs increases the cilia length in
green algae, protists, and nematodes in vivo (10–12). In cul-
tured mammalian cells, down-regulations of ICK kinase ac-
tivity lead to extended and abnormal cilia, demonstrating that
ICK is an essential regulator of the length of primary cilia
(13–16).
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As the activity of kinases is frequently modulated by
transphosphorylation by unrelated kinases, the ciliary kinases
represent potential sites of interaction of primary cilia with
other signaling systems. In this study, we describe one
such mechanism. We unravel how FGF signaling regulates
primary cilia length, leading to direct downstream conse-
quences. Using proteomics to characterize the FGFR3 inter-
actome in cells, we identified ICK as an FGFR interactor (17).
Here, we demonstrate that FGFRs phosphorylate ICK
and partially suppress ICK kinase activity and thus employ
ICK to regulate the length and function of primary cilia
in cells.
Fig. 1. FGFRs interact with ICK, MAK, and CCRK. (A) IP of FLAG-tagged ICK with V5-tagged wild-type (WT) FGFR3 or activating FGFR3 mutant K650M in
293T cells, or (B and C) FLAG-tagged MAK or CCRK with V5-tagged wild-type FGFR3 or FGFR3-K650M in 293T cells. Actin serves as a loading control. (D) IP of
ICK with FGFR1, FGFR2, and FGFR4 demonstrating the ICK association with FGFR1 and FGFR4 but not FGFR2. (E) Wild-type NIH 3T3 cells were transfected with
FLAG-tagged ICK together with V5-tagged FGFR3; IckFlag NIH 3T3 cells were transfected only with V5-tagged FGFR3. The antibodies against protein tags were
used in the PLA (red); FGFR3 antibody was used to counterstain the transfected cells (green). As a negative control, cells were transfected with FGFR3 and an
empty vector (WT), or by GFP (WT and IckFlag). Numbers of PLA dots per cell were calculated and plotted (Student’s t test, ***P < 0.001). (Scale bars, 10 μm.)
Two clones of IckFlag NIH 3T3 cells, B11, and E5, were analyzed. (F) IP of endogenous FLAG-tagged ICK with endogenous FGFR1 in IckFlag NIH 3T3 cells; actin
serves as a loading control. (G–I) Endogenous ICK forms a complex with endogenous FGFR1 in NIH 3T3 cells. (G) Scheme of the procedure, comprising ul-
tracentrifugation, BN-PAGE, SDS/PAGE, and Western blot. (H) Cofractionalization of FGFR1 and ICK-FLAG in IckFlag(B11) NIH 3T3 cells (*). WT NIH 3T3 cells were
used as a control. (I) Native complexes (fractions #6 and/or #7) were separated using BN-PAGE, followed by second dimension SDS/PAGE. Orange box shows
separation of the ∼669-kDa complex containing FGFR1 and ICK-FLAG (arrow).
Kunova Bosakova et al. PNAS | March 5, 2019 | vol. 116 | no. 10 | 4317
CE
LL
BI
O
LO
G
Y
Results and Discussion
FGFR1, -3, and -4, but Not FGFR2, Interacts with ICK. Tandem mass-
spectrometry (MS) was used to identify novel FGFR3 interactors
among proteins coimmunoprecipitated (co-IP) with FGFR3
from cells, or among phosphotyrosine proteins isolated from
cells with activated FGFR3 signaling. In a total of 26 experi-
ments carried out in 293T cells overexpressing FGFR3, ICK
and its homolog male germ cell-associated kinase (MAK) were
found in 10 (38%) and 12 (46%) of experiments, respectively
(17). Additionally, the ICK-activating kinase, CCRK (18), was
identified in 10 (38%) experiments. The ICK association with
FGFR3 was confirmed by co-IPs of wild-type FGFR3 and ICK
expressed in 293T cells (Fig. 1A). The active FGFR3 mutant
K650M that associates with thanatophoric dysplasia (19) also
coimmunoprecipitates with ICK. FGFR3 coimmunoprecipitates
with MAK and CCRK (Fig. 1 B and C). ICK coimmunoprecipi-
tates with FGFR1 and FGFR4; no association with FGFR2 was
found (Fig. 1D).
Because 293T cells do not form cilia, we asked if ICK interacts
with FGFR3 in ciliated NIH 3T3 cells. Expressed V5-tagged
FGFR3 and FLAG-tagged ICK interacted in intact NIH 3T3
cells by proximity ligation assay (PLA) (Fig. 1E). Next, we used
CRISPR/Cas9 to insert FLAG epitope into the Ick locus in
NIH 3T3 cells, to generate cells expressing C-terminally 3xFLAG-
tagged endogenous ICK (IckFlag cells). PLA showed interaction of
endogenous ICK with expressed FGFR3 in two independent
IckFlag clones (Fig. 1E). Importantly, IP of endogenous FGFR1
from IckFlag cells demonstrated that endogenous ICK interacts
with endogenous FGFR1 (Fig. 1F). In native lysates of IckFlag
cells separated at 5–25% sucrose gradients, a cofractionation of
FGFR1 with ICK was observed (Fig. 1 G and H). Fractions rich
in both FGFR1 and ICK were resolved by blue-native (BN)-
PAGE to separate protein complexes, which were then ana-
lyzed by second-dimension SDS/PAGE to obtain their indi-
vidual components. Immunoblotting revealed an ∼669-kDa protein
complex containing FGFR1 and ICK (Fig. 1I).
To further characterize the FGFR–ICK interaction, we gen-
erated a series of FGFR3 constructs with truncations in their
intracellular domain (Fig. 2A). Mutated variants of FGFR3 were
also prepared, by targeting Y724 in the tyrosine kinase (TK)
domain, and Y760 and Y770 both located in the C-terminal tail.
The Y724/Y760/Y770 mediate interaction with signaling inter-
mediates SH2-βB, p85 PI3K, PLCγ, and GRB14 (20–22). The
binding site for the FRS2 adapter was also targeted, either by
replacing P418, L419, R425, and V427 with alanines, or by re-
moving the entire region implicated in the interaction (amino
acids 406–427) (23). FGFR3 variants were coexpressed with ICK
in 293T cells, and analyzed by co-IP. All FGFR3 variants with
deleted C terminus did not interact with ICK (Fig. 2B). Similarly,
FGFR3-Y724F and -3YF (containing triple substitution Y724F/
Y760F/Y770F) did not interact, despite having intact C termini.
Deletion of FRS2 binding site had no effect on FGFR3 in-
teraction with ICK, similar to Y760F or Y770F substitutions,
which coimmunoprecipitated with ICK normally.
Fig. 2 shows that both the C terminus of FGFR3 and Y724
are required for ICK binding. To characterize in detail the
FGFR3 epitopes involved in interaction with ICK, a peptide
microarray technology was used. Short peptides (7–22 aa)
Fig. 2. FGFR3 interacts with ICK via C terminus and
Y724. (A) Truncated or mutated FGFR3 variants
prepared for this study. Positions of point-mutated
residues are indicated in red. (B) IP of FGFR3 with
FLAG-tagged ICK in 293T cells. Actin serves as load-
ing control. FGFR3 variants lacking C terminus or
carrying the Y724F mutation did not co-IP with ICK.
Arrows indicate FGFR3.
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covering the intracellular part of FGFR3 were synthetized and
immobilized on a glass slide, incubated with recombinant ICK, and
the peptide–ICK interaction was analyzed as detailed in Materials
and Methods. Strong ICK binding was obtained for the FGFR3
peptide 740TFKQLVEDLDRVLTVTSTDEY760, located at the
boundary between the TK domain and the C terminus (SI Appendix,
Fig. S1A). Interestingly, shorter versions of this peptide, specifically
748LDRVLTVTSTDEY760 and 740TFKQLVEDLDRVLTV754,
did not show any ICK binding (Fig. 3A and SI Appendix, Fig. S1B).
Crystal structure of the FGFR3 TK domain (PDB ID code 4K33)
shows that 740TFKQLVEDLDRVLTV754 forms an α-helix fol-
lowed by an intrinsically disordered 755TSTDEY760 sequence (Fig.
3B). It is thus possible that ICK binds only to a correctly as-
sembled secondary structure in FGFR3, and not to the pep-
tides lacking either the helical or the unstructured parts of the
740TFKQLVEDLDRVLTVTSTDEY760 motif. This is supported
by the IP data, where the C-lobe of the TK domain alone or the C
terminus alone did not interact with ICK (Fig. 2B) (FGFR3-ΔC-t
and FGFR3-ΔTK). Next, we asked whether differences in the se-
quence of FGFR3 motif involved in ICK interaction could account
for the lack of FGFR2 association with ICK, observed in co-IP
experiments (Fig. 1D). We replaced the 751VLTVTSTDEY760
in FGFR3 with homologous FGFR2 sequence 760ILTLTTNEEY769,
and determined the interaction of chimeric FGFR3 (FGFR3-R2-
C-t) with ICK using co-IP. Fig. 3C demonstrates that FGFR3-
R2-C-t capacity to co-IP with ICK diminished by ∼40%, com-
pared with the wild-type FGFR3.
Our data indicate that the Y724 and C terminus of the FGFR3 are
both essential for ICK binding; FGFR3-Y724F has an intact C ter-
minus but does not bind ICK. Similarly, the FGFR3 constructs with a
deleted C terminus did not bind ICK, despite having the Y724 intact
(Fig. 2B). Thus, the ICK binding to either site is rather weak and
cooperativity between these two sites is required in the context of the
3D FGFR3 structure (Fig. 3B). Alternatively, the Y724 mediates
ICK binding indirectly, acting as an allosteric element controlling
accessibility of the C terminus for ICK.
FGF Signaling Triggers Cytoplasmic Accumulation of ICK. The asso-
ciation of wild-type FGFR3 and FGFR3-K650M with ICK was
confirmed by PLA, carried out with 293T cells expressing
V5-tagged FGFR3 and FLAG-tagged ICK (Fig. 4A). Immu-
nocytochemistry revealed an overlap of FGFR3 signal with
ICK in the cytoplasm, which contrasted with predominant
nuclear ICK localization in cells not expressing FGFR3 (Fig.
4B), suggesting that FGFRs could cause ICK’s retention in
the cytoplasm. We tested this hypothesis by determining the
ICK localization in 293T cells, where the signaling of endog-
enous FGFR1–4 (24) was activated by addition of FGFR li-
gand FGF2. Progressive cytoplasmic accumulation of ICK was
found in cells treated with FGF2 (Fig. 4 C and D). Expression
of active FGFR3-K650E or -K650M also retained ICK in the
cytoplasm (Fig. 4E). Thus, the activation of FGF signaling
alters subcellular localization of ICK, causing its cytoplasmic
accumulation.
FGFRs Phosphorylate ICK and Inhibit ICK Kinase Activity. ICK shut-
tles between the cytoplasm and nucleus (25) and this is affected
by kinase activity, as demonstrated by cytoplasmic accumulation
of the partially inactive ICK mutant R272Q (26). Because FGF
signaling altered ICK subcellular localization (Fig. 4), we asked
whether it affected ICK activity through phosphorylation. Kinase
assays utilizing recombinant FGFR3 and ICK revealed that
FGFR3 phosphorylated ICK at tyrosine residues (Fig. 5A, lane
4). Kinase assays carried out with recombinant MAK and CCRK
yielded similar results (Fig. 5 B and C, lane 4). Phosphotyrosine
mapping identified several ICK tyrosines phosphorylated by
FGFR3, among which Y15, Y156, Y495, and Y555 are con-
served in ICK and MAK in human, mouse, chick, Xenopus, and
zebrafish (Fig. 5D). Y495 and Y555 localized to an unstructured
regulatory region of ICK (amino acids 320–632 for human ICK),
making it impossible to predict the effect of their phosphoryla-
tion on ICK function. In contrast, the Y15 lies within the highly
structured ICK kinase domain. In silico modeling revealed that
phosphorylation at Y15 positions a negatively charged phosphate
moiety in immediate proximity to the pocket used for binding of
an ATP phosphate group, suggesting that phosphorylation at
Y15 down-regulates ICK kinase activity via interference with
optimal ATP binding (Fig. 5D). We tested this prediction by
determining the kinase activity of ICK, immunopurified from
293T cells in which endogenous FGFR was activated by treatment
Fig. 3. The 751VLTVTSTDEY760 motif in FGFR3 is required for the interaction with ICK. (A) Averaged fluorescence intensities from three replicates of the peptide
microarray involving peptides from FGFR3 C-terminal region. (B) Ribbon and surface representations of the crystal structure of the TK domain of FGFR3 (PDB ID
code 4K33). Residue Y724 and C-terminal region implicated in ICK binding by co-IP experiments and peptide microarray analysis are highlighted in blue and
orange/green, respectively. Orange, α-helix; green, the residue T755 (unstructured). Note that the absence of structural information for residues 756STDEY760 is
suggestive of structural disorder. (C) The putative ICK interacting motif on FGFR3 (751VLTVTSTDEY760) was replaced by the analogous sequence from FGFR2
(760ILTLTTNEEY769), creating the FGFR3-R2-C-t chimera. The co-IP of FGFR3-R2-C-t with ICK compared with wild-type FGFR3 (Student’s t test; ***P < 0.001).
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with FGF2. FGF2 induced accumulation of expressed ICK, but its
kinase activity diminished by ∼30% at the same time, as determined
in a kinase assay utilizing myelin basic protein (MBP) as a substrate
and P32-ATP to visualize ICK phosphorylation (Fig. 5E). Based on
FGF treatment producing accumulated cytoplasmic ICK, it predicts
that the degree of ICK accumulation should induce MBP phos-
phorylation at commensurate levels. However, the results show little
induction of MBP phosphorylation after FGF2 treatment, sug-
gesting partial inhibition of ICK activity by FGF (Fig. 5E). Because
the MBP kinase assay is a cell-free experiment, we tested whether
the FGF signaling inhibited ICK activity in cells. In 293T cells
coexpressing ICK and mammalian target of rapamycin (mTOR)
complex 1 protein Raptor, the levels of ICK kinase activity were
determined by detecting previously established ICK-mediated
Raptor phosphorylation at T908 (27). Treatment with FGF2
caused accumulation of ICK, but the pRaptor(T908) levels
increased only weakly, corresponding to 51–55% inhibition of
relative ICK activity (Fig. 5F). These experiments demonstrate
that interaction with FGFRs stabilizes cytoplasmic ICK while
partially downregulating its kinase activity.
FGF Signaling Regulates the Cilia Length via ICK. Because both ICK
and FGF regulate cilia length (4, 15), we asked whether FGF
signaling regulates cilia via ICK. NIH 3T3 cells were serum-
starved for 12 h to produce primary cilia, treated with FGF2
for up to 24 h, and cilia were visualized by immunostainings for
the axoneme (acetylated tubulin), ciliary membrane (ARL13B),
and centrioles (pericentrin). FGF2 triggered progressive increase
in cilia length peaking at 12 h (3.13 ± 0.05 μm vs. 2.33 ± 0.04 μm
in controls) (Fig. 6A). Transfection of two independent Ick short-
hairpin (sh)RNAs resulted in ∼20–40% knockdown of Ick
expression in NIH 3T3 cells, with corresponding (11–18%) ex-
tension of primary cilia length, compared with nontransfected
controls or cells transfected with scrambled shRNA (Fig. 6B).
Importantly, the cilia in Ick shRNA cells were resistant to FGF2-
mediated elongation, in contrast to scramble shRNA or control
cells, which responded to FGF2 with cilia elongation (31–33%).
Next, we down-regulated ICK in IckFlag(B11) NIH 3T3 cells by stable
transfection of doxycycline (DOX)-inducible lentiviral shRNA
construct. DOX caused ∼67% down-regulation of the ICK
protein. DOX-induced cells were resistant to FGF2-mediated
cilia elongation, in contrast to controls, which responded to
FGF2 with cilia elongation (Fig. 6C). Finally, we tested whether
chemical inhibition of ICK kinase activity affects cilia length.
According to the DrugKiNET database (www.drugkinet.ca), fla-
vopiridol, AT7519, and lestaurtinib act as chemical ICK inhibitors,
with KD values of 0.69 nM, 8.3 nM, and 39 nM, respectively (28).
NIH 3T3 cells treated with flavopiridol, AT7519 or lestaurtinib
showed concentration-dependent deregulation of cilia length.
Importantly, FGF2 failed to elongate these cilia (SI Appendix,
Fig. S2).
Next, the Ick locus in NIH 3T3 cells was inactivated by
CRISPR/Cas9. A sequence corresponding to Glu80 in ICK was
targeted, because it localizes to the ATP binding pocket and its
substitution with Lys abolishes ICK kinase activity (16). We
failed to generate IckE80K cells, but nevertheless produced clones
with disrupted Ick. Interestingly, none of the 302 clones obtained
in three rounds of CRISPR targeting possessed complete in-
activation of all three Ick loci in triploid NIH 3T3 cells (29),
suggesting that some level of ICK protein is essential for NIH
3T3 growth. Three clones were selected for further analyses, in
which the two Ick alleles were inactivated, and the remaining one
allele contained in frame deletions ranging from 3 to 14 residues
surrounding the Glu80 (Fig. 7A). IckmRNA was down-regulated
to about 40–60% among the selected clones, but the protein
levels remained unchanged (Fig. 7 B and C), again suggesting
that presence of the ICK protein is necessary for NIH
3T3 survival. The ICK deletions generated by CRISPR were
introduced into the wild-type ICK via site-directed mutagene-
sis, and the resulting ICK variants were evaluated for kinase
Fig. 4. FGF signaling alters ICK’s subcellular distribution. (A) 293T cells were transfected with FLAG-tagged ICK together with V5-tagged wild-type FGFR3 or
its active mutant K650M. The antibodies against protein tags were used in the PLA (red); FGFR3 antibody was used to counterstain the transfected cells
(green). As a negative control, cells were transfected with FGFR3 and an empty vector. Numbers of PLA dots per cell were calculated and plotted (Student’s
t test, ***P < 0.001). (Scale bar, 10 μm.) (B) Increased cytosolic localization of transfected ICK in a 293T cell cotransfected with FGFR3-K650E, determined by ICK
and FGFR3 immunocytochemistry (Scale bar, 20 μm.). (C and D) Altered ICK subcellular distribution in 293T cells expressing FLAG-tagged ICK, treated with
FGF2; ICK was visualized by FLAG immunocytochemistry. (C) Typical localization patterns of ICK (DIC, differential interference contrast). (Scale bar, 20 μm.) (D)
Percentages of cells in each category of ICK localization (Student’s t test, **P < 0.01). (E) 293T cells were transfected with FLAG-tagged wild-type FGFR3, active
FGFR3-K650E, or K650M, or empty vector, and immunoblotted for phosphorylated (p) FGFR3. ICK and FGFR3 were visualized by immunocytochemistry, and
ICK subcellular localization was determined.
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activity in 293T cells. We observed a dramatic reduction in ICK
activating autophosphorylation at the Y159 (25) in all three
CRISPR variants, compared with wild-type ICK, demonstrating that
IckCRISPR cells express normal levels of kinase-dead ICK (Fig. 7D).
Severe abnormalities were found in the cilia of IckCRISPR cells,
which we termed a “cilia disaster” phenotype. These cilia were
highly variable in length (0.4–6.9 μm; CV 65.14%; n = 296),
compared with relatively narrow range in control cells (1.2–
4.4 μm; 22.05%; n = 409) (SI Appendix, Fig. S3). The IckCRISPR
cilia displayed abnormal morphology, often manifested as rudi-
ments negative for acetylated and polyglutamylated tubulin (Fig.
7E, Bottom). Long and twisted cilia in some IckCRISPR cells also
appeared less stable than wild-type cilia, as suggested by lesser
axoneme staining for acetylated tubulin (30) (Fig. 7E, arrow).
IckCRISPR cells showed profound disruption of Hh signaling,
manifested as failure to process the GLI3 transcriptional regu-
lator in response to Hh agonist SAG (SMO agonist) (31), and to
induce expression of Hh target genes Gli1 and Ptch1 (SI Ap-
pendix, Fig. S4 A–C). Mislocalization of GLI3 and the compo-
nents of the cilia transport BBS8 and intraflagellar transport
(IFT)172 was found in the IckCRISPR cilia tips (SI Appendix, Fig.
S4D). Finally, the Hh coreceptor SMO localized into the cilia in
SAG-naïve IckCRISPR cells, in contrast to wild-type controls,
which localized SMO to cilia only when treated with SAG
(SI Appendix, Fig. S4E), suggesting increased permeability
in IckCRISPR cilia.
FGF2 did not elongate cilia in any of the three IckCRISPR
clones; however, the informative value of this data may be af-
fected by the profound ciliary dysregulation (Fig. 7F). Addition
of wild-type ICK into the IckCRISPR background partially re-
versed the cilia disaster phenotype, resulting in formation of
many cilia of normal length, which responded to FGF2 with
usual elongation (Fig. 7G). Addition of kinase-dead ICK-E80K
also rescued the cilia disaster; however, these cilia were longer
than those in wild-type ICK add-back cells and, importantly,
were resistant to FGF2-mediated elongation (Fig. 7G).
We next evaluated the effect of FGF2 on cilia length in fibroblasts
established from an individual with lethal short rib polydactyly syn-
drome due to an inactivating E80K mutation in ICK (16). Com-
pared with control fibroblasts, ICK-E80K cells exhibited greater
range in their cilia length distribution, with many long and twisted
cilia (Fig. 7H). Treatment with FGF2 caused statistically significant
cilia elongation in control fibroblasts but not in ICK-E80K cells.
Finally, the limb bud micromass cultures were used to evaluate
the FGF2 effect on cilia. FGF2 caused primary cilia extension in
micromasses established from embryonic day 12 (E12) mouse
limb buds isolated from wild-type or Ick+/− mice (Fig. 7I) (4).
Importantly, this effect depended on ICK, as cells derived from
Ick−/− mouse limb buds (13) were insensitive to FGF2-mediated
Fig. 5. FGFRs phosphorylate and partially inactivate ICK. (A–C) Tyrosine phosphorylation of ICK, MAK, or CCRK in cell-free kinase assay with recombinant
FGFR3 and recombinant ICK, MAK or CCRK, detected by Western blot with pY antibody. (D) FGFR3-mediated tyrosine phosphorylation of ICK in cell-free
kinase assay analyzed by MS. Footnotes: (1) Tyrosine position relative to human ICK sequence (NP_055735.1); (2) number of experiments varies due to limited
sequence coverage in some MS samples; (3) conservation in Homo sapiens ICK/MAK, Mus musculus Ick/Mak, Gallus gallus ICK/MAK, Xenopus laevis ick/mak,
Danio reriomak, Drosophila melanogaster DmeI_CG42366; (4) conservation in H. sapiens,M. musculus, G. gallus, X. laevis, D. rerio but not in D. melanogaster;
(5) representative peptide sequence found in MS, pY underlined; (6) ICK activating dual phosphorylation motif T157-D-Y159; (7) conservation only in ICK, not in
MAK. (Middle) Sequence alignment of N-terminal region of ICK, conserved residues in gray; Y15 in red. (Bottom Left) Three-dimensional homology model of
ICK kinase domain showing ATP binding site, activation loop, and substrate binding site in yellow, green, and purple, respectively, Y15 in red. (Bottom Right)
Electrostatic representation of ATP binding site with bound ATP. Electronegative and electropositive sites are in blue and red, respectively. (E) The kinase
activity of ICK immunoprecipitated from FGF2-treated 293T cells, measured using MBP as a substrate, in the presence of [32P]-ATP. ICK activity is presented
as a relative [32P]MBP/MBP ratio (“Obtained”), and compared with the expected values based on ICK amounts entering the kinase assay quantified using
Coomassie stained gel (ICK Coomassie) or ICK immunoblot (ICK IP) (Student’s t test, ***P < 0.001). The percentages express the extent of inhibition of the ICK
kinase activity in FGF2-treated cells. (F) ICK kinase activity in 293T cells treated with FGF2, determined as a degree of ICK-mediated Thr908 phosphorylation of
expressed Raptor. The ICK activity is presented as a relative pRaptor/Raptor ratio (“Obtained”) and compared with the expected values based on ICK levels.
The percentages express the extent of inhibition of the ICK kinase activity in FGF2-treated cells.
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cilia elongation. Taken together, the ICK deletion or down-
regulation of ICK kinase activity rescued the FGF-mediated
elongation of primary cilia. These findings establish that FGF
signaling regulates cilia length via ICK.
Because ICK inactivation inhibits Hh signaling, we analyzed
the Hh activity in several models to ICK inhibition. The Sonic
hedgehog (Shh)-LIGHT2 NIH 3T3 cells stably express the GLI-
driven Firefly luciferase reporter capable of monitoring the Hh
pathway activity (32). We inhibited endogenous Ick activity by
treatment with FGF2 in Shh-LIGHT2 cells, and analyzed the
transactivation of the Hh reporter. At the maximal induction
obtained with 100 nM SAG, FGF2 inhibited the luciferase
activity by 37% (SI Appendix, Fig. S5A). Similarly, inhibition
of Ick activity in NIH 3T3 cells using flavopiridol, AT7519, or
lestaurtinib abolished the SAG-mediated GLI1 up-regulation,
as did FGF2 (SI Appendix, Fig. S5B). Finally, micromasses
derived from murine Ick−/− limb buds failed to efficiently up-
regulate Gli1 and Ptch1 expression and ciliary GLI2 localization
upon SAG, similarly to the FGF2-treated control micromasses (SI
Appendix, Fig. S5 C and D).
Regulation of Primary Cilia by FGF–ICK Pathway. The regulation of
primary cilia length and function by FGF signaling has recently
emerged as a new paradigm in cell biology (3–5). However, the
molecular mechanism by which FGFs regulate cilia remains
unclear. In this article, we uncover that FGFRs interact with and
phosphorylate an important and conserved ciliary kinase, ICK,
leading to partial inhibition of its kinase activity and altered
subcellular localization (Figs. 1–5). Modulations of FGF signal-
ing regulate primary cilia length, IFT velocity, and Hh signaling
consistent with effects caused by its inhibition of ICK activity (3,
4, 15, 16, 33). Moreover, ICK removal or down-regulation
abolished the FGF-mediated effect on ciliary length (Figs. 6
and 7), demonstrating that FGF signaling regulates primary cilia
via ICK. In the following section, we describe known cilia phe-
notypes regulated by FGF signaling, and explain these pheno-
types on the basis of the FGF–ICK interaction (Fig. 8).
First, the ICK is a sensitive regulator of primary cilia length.
Deletion of ICK homologs LF4, LmxMPK9, and DYF-5 increased
the length of cilia in green algae (Chlamydomonas reinhardtii),
protists (Leishmania mexicana), and worms (Caenorhabditis elegans)
(10–12). Similarly, Ick−/− mice or humans carrying partially or
completely inactivating ICK mutations R272Q and E80K showed
elongated primary cilia (13, 16, 34). Expression of these variants and
other inactive ICK mutants in cultured cells, or partial down-
regulation of Ick expression via RNA interference also elongated
primary cilia (13–16, 35). Because FGFRs phosphorylate and in-
activate ICK (Fig. 5), a down-regulation of FGF signaling should
relieve this inhibition, resulting in elevated ICK activity and shorter
cilia (Fig. 8B). Indeed, mice treated with chemical inhibitors of
FGFR activity showed shorter cilia in the biliary ducts, kidney, and
lung (4). This is corresponding to the evidence obtained in zebrafish
and Xenopus, where inactivation of Fgf signaling led to shorter cilia
in multiple tissues (3). Similar to ICK inactivation, stimulation of
FGF signaling elongated primary cilia in NIH 3T3 cells, primary
mouse embryonic and human fibroblasts, epithelial IMCD3 cells,
and mouse limb bud mesenchymal cells (4), but failed to do so in
Ick−/− background or in cells endogenously expressing inactive ICK
(Fig. 7). Similarly, cells with diminished Ick expression or activity
were insensitive to the FGF-mediated cilia elongation (Fig. 6),
demonstrating that FGF signaling elongates primary cilia via in-
hibition of ICK kinase activity (Fig. 8C).
While inhibition of ICK activity extended primary cilia, experi-
mental up-regulation of ICK activity produced shorter cilia (11–13,
16, 33). Interestingly, ICK inactivation also led to cilia shortening in
at least two instances, in the neural tube and embryonic fibroblasts
isolated from an Ick−/− mice (33), and in the NIH 3T3 IckCRISPR
cells reported here (Fig. 7 A–G and SI Appendix, Fig. S3) (the cilia
disaster phenotype). In our previous work, we showed that FGF
signaling can also shorten primary cilia (4, 5), as observed in cells
expressing constitutively active FGFR3-K650E or -K650M
mutants. Interestingly, these FGFR3 mutants interacted with
ICK (Fig. 1). Thus, the FGF-mediated ICK inactivation may
lead to profound dysregulation of ciliogenesis manifested as
cilia shortening or extension, depending on the strength and
duration of the FGF stimulus (Fig. 8D).
Ick−/− mouse models described by both Chaya et al. (33) and
Moon et al. (13) displayed preaxial polydactyly and dwarfism, a
similar phenotype to human short-rib polydactyly syndrome as-
sociated with an inactivating ICK mutation (16), or to mice and
humans with endocrine-cerebro-osteodysplasia syndrome cou-
pled with mildly inactivating ICK mutations (26, 35, 36). These
phenotypes suggest impaired Hh signaling, as polydactyly stems
from defective Hh function in early limb patterning (37), while
the shortened appendicular skeletons likely result from disrupted
Fig. 6. FGF regulates the length of primary cilia via ICK. (A) Primary cilia
length extension in NIH 3T3 cells treated with FGF2. Cilia were visualized by
ARL13B, acetylated tubulin (AcTu) and pericentrin immunostaining, mea-
sured in 3D and plotted. Black dots, individual cilia; red bars, medians. [Scale
bars: 5 μm (cells) and 1 μm (cilia).] (B) Rescue of FGF2-mediated cilia exten-
sion with two independent Ick shRNAs (Ick #1 and Ick #2). Ick transcript levels
were monitored by qPCR at 24 h (beginning of serum starvation) and 36 h
(FGF2 treatment) after transfection, and normalized to Gapdh expression.
The columns show Ick expression levels relative to the scrambled control (red
dashed line). Cilia length was measured 48 h after transfection and graphed.
(C) Rescue of FGF2-mediated cilia extension in IckFlag(B11) NIH 3T3 cells stably
transfected with DOX-inducible shRNA-expressing construct targeting ICK
expression. ICK protein levels were monitored by immunoblot after 4 d with
DOX (beginning of FGF2 treatment), normalized to actin, and plotted. Cells
expressing scrambled (Scr.) shRNA upon DOX were used as a control. Stu-
dent’s t test, **P < 0.01, ***P < 0.001; n.s., not significant.
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Hh regulation of chondrocyte proliferation in the growth plate
cartilage (38). Indeed, poor and mislocalized expression of Hh
target genes Gli1, Ptch1, and HoxD13 was found in the growing
skeleton of the Ick−/− mice (13, 16). However, the two Ick−/−
mouse models had differing ciliary length consequences. Ick−/−
mice reported by Chaya et al. (33) had shortened primary cilia, yet
the Moon et al. (13) mouse model showed extended primary cilia,
demonstrating that both extension and shortening of primary cilia
due to ICK insufficiency adversely affects Hh signaling. Similar
effects were induced by experimental activation of FGF signaling,
when both extension of primary cilia caused by transient FGFR
activation, or shortening of cilia induced by constitutive FGF sig-
naling, lead to similar attenuation of cell response to Hh signal (4).
In this study, we demonstrate that FGFR interacts with ICK to
regulate cilia length. Several questions remain to be addressed to
fully understand the process. First, it is unclear where in cell the
FGFR–ICK interaction takes place. Because ICK, FGFR1, and
FGFR3 are known to localize to the cilia (5, 13–16, 33, 35, 39,
40), it is possible that they interact in the cilium or in its basal
body. Alternatively, the FGFRs may interact with ICK outside of
the cilia. We and others (16, 25) show that the majority of the ICK
protein shuttles between nucleus and cytosol, and activation of
FGF signaling causes ICK retention in the cytoplasm. This sug-
gests that FGFRs may alter intracellular distribution of ICK, thus
impeding ICK cilia function by its sequestration away from cilia, in
addition to partial inactivation. Second, despite numerous reports
describing an essential role of ICK in maintenance of proper cilia
form and function, the molecular mechanism of this phenotype is
poorly known. ICK phosphorylates Kif3a (13), but how this
phosphorylation affects Kif3a function or IFT velocity is not
known. Further understanding of the FGF–ICK regulation of cilia
will provide insights into the pathology of Mendelian inherited
disorders and cancers caused by defective FGF signaling.
Materials and Methods
Cell Culture, Vectors, Transfection, RNAi, CRISPR/Cas9, Lentiviruses, and qPCR.
The 293T andNIH 3T3 cells were obtained fromATCC. Shh-LIGHT2 cells were a
kind gift from P. Beachy, Stanford University School of Medicine, Stanford,
CA (32). Control and ICK-E80K fibroblasts were established by an In-
ternational Skeletal Dysplasia Registry, and obtained from the Registry un-
der an approved University of California, Los Angeles human subjects
protocol involving informed consent. Cells were propagated in DMEM me-
dia, supplemented with 10% FBS and antibiotics (Invitrogen). FGF2 was from
R&D Systems, SAG from Millipore, leastaurtinib and flavopiridol from Tocris,
AT7519 from Selleckchem. Cells were transfected using the FuGENE6
(Promega), Lipofectamine 2000 (Invitrogen), or by electroporation using the
Fig. 7. FGF increases cilia length via ICK. (A) CRISPR/
Cas9 targeting of Ick in triploid NIH 3T3 cells. IckCRISPR
#1–3, three clones with all three alleles targeted; the
positions of deletions are indicated (N.m.d., nonsense
mediated decay). (B) Ick expression was analyzed by
qPCR, and normalized to Gapdh. (C) ICK protein levels
were analyzed by Western blot. (D) 293T cells were
transfected with FLAG-tagged wild-type ICK, kinase-
dead ICK-E80K or ICK variants harboring in-frame
deletions as shown in A, and Western blot for ICK
activating phosphorylation (p) at Y159 was used to
determine the kinase activity. (E) Cilia in IckCRISPR cells
were visualized by ARL13B, acetylated tubulin (AcTu),
polyglutamylated tubulin (PolygluTu) or γ-tubulin
(γTu) immunostaining. Both long and extremely
short cilia signals are shown for IckCRISPR cells. (Scale
bar, 1 μm.) Missing AcTu staining is indicated (arrow).
(F) IckCRISPR cells were treated with FGF2 for 12 h and
the cilia length was measured; black dots, individual
cilia; red bars, medians. (G) IckCRISPR #3 cells were
transfected with wt ICK or ICK-E80K, treated with FGF2,
and the cilia length was measured. GFP transfection was
used as a control. FGF2 extended primary cilia length in
wild-type ICK add-back cells but not in ICK-E80K cells.
(H) Human control and ICK-E80K fibroblasts were serum
starved and immunostained to visualize cilia. (Scale bar,
1 μm.) Cells were treated with FGF2 and the cilia length
was measured. (I) Micromasses produced from limb
buds of either Ick+/+ (control) or Ick−/− E12 mouse lit-
termates were treated with FGF2 for 24 h and stained
with hematoxylin or ARL13B/γ-tubulin. [Scale bars:
1 mm (Left) and 5 μm (Right).] The cilia lengths were
measured and graphed. Student’s t test, **P < 0.01,
***P < 0.001; n.s., nonsignificant.
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Neon Transfection System (Invitrogen). The following vectors were used:
FGFR1–4 (41, 42); pmaxGFP (Lonza); Raptor (43); ICK, MAK, and CCRK (Ori-
gene). The ICK mutation E80K was described previously (16); the ICK mutants
were generated by site-directed mutagenesis (Agilent Technologies). Trun-
cated and mutated FGFR3 variants were generated by PCR mutagenesis.
SureSilencing shRNA plasmid (KM37622G, clones #1 and #2; Qiagen) and
scrambled control NEG4-G were used for RNAi; the GFP expression was used to
identify shRNA-expressing cells. CRISPR/Cas9 was used as described previously
(44). A pair of SpCas9n (D10A) nickases targeting 5′-ACTCGAAGATAAA-
GTAAAGATGG-3′, 5′-CTTTATCTTCGAGTACATGAAGG-3′ sites in the fourth
exon of Ick were used, and cotransfected with pmaxGFP. GFP+ cells were picked
to grow single-cell clones. Targeting was confirmed by PCR sequencing. To
generate IckFlag cells, NIH 3T3 cells were transfected with a pair of nickases
targeting 5′-AGTACCCATCCCGGCGGTGA-3′ and 5′-GCGGTGACTGTCCCGGC-
CA-3′ sites at the end of the last exon together with synthetic DNA (gBlock,
IDT) containing 3xFlag sequence surrounded with 451- and 491-bp long
homology arms at left and right. Single-cell colonies which were screened by
Western blot for the presence of Flag tag at Ick. Targeting was verified by
PCR sequencing. A lentiviral vector containing DOX-inducible U6 promoter
and TetRep-P2A-Puro-P2A-mCherry (45) was modified to express shRNA by
introducing oligonucleotides (shIck forward: ccggcacaaccacgaggcggtgtaa-
ctcgagttacaccgcctcgtggttgtgtttttg, reverse: attcaaaaacacaaccacgaggcg-
gtgtaactcgagttacaccgcctcgtggttgtg; Scrambled forward: ccgggcgta-
ccaaccggaactgagactcgagtctcagttccggttggtacgtttttg; reverse: aattcaaaa-
agcgtaccaaccggaactgagactcgagtctcagttccggttggtacgc). Lentiviral particles were
generated as described previously (46) using pMD2.G (Addgene #12259) and
psPAX2 (Addgene #12260) (gift from Didier Trono, École Polytechnique Féd-
érale de Lausanne, Lausanne, Switzerland). IckFlag NIH 3T3 cells were trans-
duced using generated lentiviral particles and mCherry+ cells were sorted using
BD FACSAria (BD Biosciences). Cells were treated with 1 μg/mL DOX (Sigma-
Aldrich) to induce the shRNA expression for 4 d. Total RNA was isolated using
RNeasy Mini Kit (Qiagen) and reverse-transcribed by First Strand cDNA Syn-
thesis Kit (Roche). For qPCR, the following QuantiTect Primers were used
(Qiagen): Mm_Ick_1_SG (QT01037729), Mm_Gapdh_3_SG (QT01658692),
Mm_Ptch1_1_SG (QT00149135), and Mm_Gli1_1_SG (QT00173537). For
micromasses, the following primers were used in qPCR: Gli1 (5′-CTTGTGGTGGAGT-
CATTGGA-3′, 5′-GAGGTTGGGATGAAGAAGCA-3′), Ptch1 (5′-AATTCTC-
GACTCACTCGTCCA-3′, 5′-CTCCTCATATTTGGGGCCTT-3′), Gapdh (5′-CCT-
GTTGCTGTAGCCGTATT-3′, 5′-AACAGCAACTCCCACTCTTC-3′).
Gradient Ultracentrifugation, BN-PAGE, Western Blot, IP, Kinase Assays, and
Peptide Microarrays. Native cell lysates (50 mM Tris·HCl pH 7.4, 150 mM
NaCl, 0.5% Igepal CA-630, 1 mM EDTA pH 8, 0.25% sodium deoxycholate,
1 mM Na2VO4, proteinase inhibitors) were cleared, loaded on 5–25% sucrose
gradient (1 mM Tris·HCl pH 7.4, 150 mM NaCl, 3 mM MgCl2, proteinase in-
hibitors), and centrifuged at 40,000 rpm/4 °C/16 h using SW 40 Ti swinging
bucket rotor (Beckman Coulter). Gradient fractions were either precipitated
with 10% TCA or used for BN-PAGE. For BN-PAGE, fractions were mixed with
solubilization buffer (50 mM NaCl, 50 mM imidazole/HCl, 1 mM EDTA, pH 7)
and concentrated using Spin-X UF 500 (cut-off 30 kDa; Corning). Before
sample loading, the wells of the 4–15% native tricine-imidazole gel were
washed with cathode buffer (50 mM tricine, 7.5 mM imidazole, 0.02%
Coomassie blue G250, pH ∼ 7), and the gel run at constant 15 mA/4 °C. The
29- to 669-kDa native protein ladder was from Sigma. Individual lanes were
cut from the gel, placed over the SDS gel, and protein complexes were
separated using second dimension SDS/PAGE, and analyzed by Western blot.
For Western blot, lysates were resolved by SDS/PAGE, transferred onto a
PVDF membrane and visualized by chemiluminiscence (Thermo). The fol-
lowing antibodies were used: GAPDH (5174), GLI1 (2643), FGFR1 (9740), actin
(3700; Cell Signaling); HA (sc-805), FGFR3 (sc-123), pFGFR3Y724 (sc-33041;
Santa Cruz Biotechnology); FLAG (F1804), GST (G1160; Sigma); V5 (R960-
25; Invitrogen), 4G10 (05-321; Millipore), pICKY159 (ab138435; Abcam), GLI3
(AF3690; RnD Systems), ICK (43), and pRaptorT908 (27). For IP, cells were
extracted in buffer containing 50 mM Tris·HCl pH 7.4, 150 mM NaCl, 0.5%
Nonidet P-40, 0.1% sodium deoxycholate, 2 mM EDTA pH 8.0, 0.5 mM DTT,
proteinase inhibitors; immunocomplexes were collected on protein A/G
agarose (Santa Cruz). Kinase assays were performed using recombinant
FGFR3 together with ICK, MAK, or CCRK (SignalChem), in kinase buffer
(60 mM Hepes pH 7.5, 3 mMMgCl2, 3 mMMnCl2, 3 μM Na3VO4, 1.2 mM DTT)
in the presence of 10 μM ATP. Tyrosine phosphorylation was determined by
Western blot with 4G10 antibody (Millipore). [32P]-ATP kinase assays were carried
out with IP ICK and 4 μg of recombinant MBP (Sigma) as a substrate, in a kinase
buffer (50 mM Hepes pH 7.5, 10 mM MnCl2, 10 mM MgCl2, 8 mM β-glycer-
ophosphate, 1 mMDTT, 0.1 mMNa3VO4, 0.1 mM PMSF), in the presence of 1 μCi
[32P]-ATP (Izotop). Samples were resolved by SDS/PAGE and visualized by auto-
radiography. Band intensities were quantified in ImageJ. Peptide libraries cor-
responding to FGFR3 intracellular domain were synthetized and immobilized on
a glass slide via hydrophilic linker (Pepstar microarray; JPT Peptide Technologies).
The library contained overlapping peptides (13-aa long with 10-aa overlap)
covering disordered parts of FGFR3 in the juxtamembrane and C-terminal re-
gions, and nonoverlapping peptides of varying length that emulated elements
of the secondary structure exposed on the surface of FGFR3 TK domain (FGFR3:
4K33) (SI Appendix, Fig. S1B). Microarrays were incubated with recombinant ICK
(I01-10G; SignalChem), labeled by DyLigh 650 (ThermoFisher Scientific). Fluores-
cence intensities were obtained using laser scanner Axon Genepix Scanner 4300
SL50, and quantified using GenePix (Molecular Devices). The peptides with
fluorescence intensity at least 10-fold above nonspecific were considered as
potential binding sites. Microarray preparation, data acquisition, and analysis
were described previously (47).
Immunocytochemistry, PLA, and Cilia Length Measurements. Cells were fixed in
paraformaldehyde and incubated with the following antibodies: V5 (R960-
25), acetylated α-tubulin (32-2700; Invitrogen), FLAG (F1804; Sigma),
ARL13B (17711-1-AP; Proteintech), γ-tubulin (ab11316), pericentrin (ab4448;
Abcam), polyglutamylated tubulin (AG-20B-0020-C100; AdipoGen), SMO (sc-
166685), BBS8 (sc-271009), IFT172 (sc-398393; Santa Cruz), and GLI3 (AF3690;
RnD Systems). Duolink PLA (Sigma) was used for PLA, with V5 (sc-83849;
Santa Cruz) and FLAG (F1804; Sigma) antibodies; FGFR3 (sc-123; Santa
Cruz) was used to counterstain the transfected cells. AlexaFluor488/594 sec-
ondary antibodies were from Invitrogen. PLA analysis was done in Fiji (fiji.sc/)
using maximum projections of z-stacks. Cilia length in 3D were determined
as described previously (16).
MS, Modeling, Animal Experiments, Immunohistochemistry, and Statistics. Ki-
nase reactions containing FGFR3 and ICK were subjected to reduction, al-
kylation, and in-solution digestion by trypsin. Samples were analyzed using
nanoscale liquid chromatography connected to the tandem mass spec-
trometer (RSLCnano connected to Orbitrap Elite; Thermo Fisher). High-
resolution HCD or ETD MS/MS spectra were acquired in the Orbitrap
analyzer. The analysis of the MS RAW data files was carried out using the
Proteome Discoverer software (v.1.4; Thermo) with a Mascot search engine
(v.2.4.1; Matrix Science). Quantitative information assessment and phos-
phopeptide signal validation was done in Skyline. The 3D ICK model was
obtained via template-based homology modeling using the PHYRE software
(48). The ICK-specific functional elements, predicted using the National
Fig. 8. Model describing regulation of primary cilia length by the FGF–ICK
pathway. (A) Under basal conditions, endogenous FGF signaling restricts ICK
activity to the level required for optimal length of the cilia. (B) Experimental
up-regulation of ICK activity, by increased expression of active ICK, shortens
the primary cilia (12, 15, 16). Similar effect is achieved in cells with abolished
FGF signaling, which are unable to inhibit ICK, leading to up-regulation of
ICK kinase activity and ciliary shortening (3, 4). (C) Down-regulation of ICK
activity, either by transient increase in activity of FGF signaling, or by small
chemicals, expression of kinase-inactive ICK mutants (*), Ick knockout or
knockdown, extends primary cilia (4, 12, 13, 15, 16, 33). (D) Under certain
conditions, inactivation of ICK results in profound dysregulation of primary
cilia (cilia disaster), manifested by low cilia stability and extreme length vari-
ability (10, 33). A similar phenotype is achieved by strong activation of FGF
signaling via disease-associated FGFR3 mutations (*) (4, 5), suggesting that the
strength of the FGF stimulus regulates optimal ciliary length through ICK.
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Center for Biotechnology Information Conserved Domain Database (49), were
mapped onto a 3D model of the ICK using the CHIMERA software (50). Ho-
mology modeling (PDB ID codes 3C4W and 1JNK) was employed to dock ATP
into the ICK ATP binding site. Ick−/−mice were described previously (16). Ick+/−
mice were maintained in a C57/BL6N background and used as controls. For
micromasses, the primary mesenchymal cells were harvested from the limb
buds of E12 mouse embryos, digested with dispase II, and spotted in 10-μL
aliquots at 2 × 107 cells/mL. Cells were allowed to adhere before differenti-
ating media (60% F12/40% DMEM, 10% FBS, 50 μg/mL ascorbic acid, 10 mM
β-glycerol phosphate, 1% L-glutamine) was added. Micromasses were grown
for 1 d in media supplemented with FGF2 (Sigma), fixed with methanol and
paraformaldehyde, and immunolabeled by ARL13B and γ-tubulin (T6557;
Sigma) antibodies. For GLI2 detection, micromasses were serum-starved for
12 h, treated with FGF2 and SAG for additional 12 h, and immunostained
using GLI2 and ARL13B antibodies (13). Animal experiments were approved by
the Institutional Animal Care and Use Committee of Dongguk University,
Korea (IACUC-2016-016-1). All experiments were performed at least in tripli-
cate unless stated otherwise. The n values express the number of independent
biological experiments. Data are presented as mean ± SEM. Two-tailed Stu-
dent’s t test was used for statistical analysis of data. Brightness and contrast
were adjusted in microphotographs, homogenously throughout each panel.
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